Blog
RSS FeedPosted by Michael Wonder on 24 Oct 2017
AMA submission - Government proposals to increase biosimilar prescribing
19 October 2017 - The Australian Medical Association encourages medical practitioners to offer generic medicine choices when it is safe and ...
Posted by Michael Wonder on 11 Oct 2017
The future of drug pricing: value over volume
11 October 2017 - Doctors and hospitals are increasingly being paid not for the quantity of care they provide, but ...
Posted by Michael Wonder on 23 Sep 2017
FDA clears biotech drug copycats, but buying them isn’t so easy
18 September 2017 - Basically, there’s a gazillion patents,’ says consultant. ...
Posted by Michael Wonder on 16 Aug 2017
What’s harder than making copycat biotech drugs? Selling them
15 August 2017 - Payer pacts, wary patients vex the market for biosimilar drugs. ...
Posted by Michael Wonder on 09 Aug 2017
Unlicensed and off-label uses of medicines: definitions and clarification of terminology
5 August 2017 - The terms “licensed”, “unlicensed”, and “off-label”, often used in relation to marketing and prescribing medicinal products, ...
Posted by Michael Wonder on 09 Aug 2017
Drug makers' hopes for gene therapy rise despite tiny sales in Europe
8 August 2017 - The science of gene therapy is finally delivering on its potential, and drug makers are now ...
Posted by Michael Wonder on 27 Jul 2017
EU report: more evidence on link between antibiotic use and antibiotic resistance
27 July 2017 - The European Food Safety Authority, the European Medicines Agency and the European Centre for Disease Prevention ...
Posted by Michael Wonder on 24 Jul 2017
Government moves to legislate to increase generic and biosimilar medicine uptake and cut medicine prices
24 July 2017 - Australia has long lagged behind the USA and UK in its use of generic pharmaceuticals – ...
Posted by Michael Wonder on 24 Jul 2017
NHS England consults on blocking ‘wasteful’ prescriptions
24 July 2017 - NHS England has unveiled detailed proposals of how prescriptions for “ineffective, over-priced and low value treatments” ...
Posted by Michael Wonder on 15 Jul 2017
Returns to scientific publications for pharmaceutical products in the United States
10 July 2017 - Drug-specific clinical and health economic and outcomes research (HEOR) publications have amassed, but their effect on drug ...
Posted by Michael Wonder on 09 Jul 2017
'Extreme': Australian GPs prescribing antibiotics at up to nine times recommended rates, study funds
9 July 2017 - Australian GPs are prescribing antibiotics at up to nine times recommended rates, a new study has ...
Posted by Michael Wonder on 02 Jul 2017
Over 16,000 Australian children prescribed antipsychotics, PBS data shows
3 July 2017 - A mufti day at school, knee-length shorts and a teenage taunt triggered Kalei's first panic attack. ...
Posted by Michael Wonder on 13 Jun 2017
Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is taking new steps to help assess opioid drugs with abuse-deterrent properties
13 June 2017 - Last month, I asked my colleagues at the FDA to identify what additional and more forceful steps ...
Posted by Michael Wonder on 02 May 2017
Budget 2017: Peak GP body supports Government's generic drug scheme but medical community split
2 May 2017 - Australia's peak GP group has come out in support of a government proposal to encourage doctors ...
Posted by Michael Wonder on 01 May 2017
Obstacles to the adoption of biosimilars for chronic diseases
1 May 2017 - Biologic agents have an increasingly important role in clinical care, accounting for 22% of new US FDA ...